NCT03952494 (MyGenes) is a NA clinical trial of Genomind®Professional PGx Express TM in Depression, sponsored by Weill Medical College of Cornell University.

Who is sponsoring NCT03952494?

NCT03952494 is sponsored by Weill Medical College of Cornell University.

What drugs are being tested in NCT03952494?

Interventions in NCT03952494: Genomind®Professional PGx Express TM.

What condition does NCT03952494 study?

NCT03952494 studies Depression.

Is NCT03952494 still recruiting?

NCT03952494 is currently withdrawn. Last updated 8 November 2021.

Last reviewed 2021-11-08 · How we verify

NCT03952494: MyGenes

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Individualizing Antidepressant Treatment Using Pharmacogenomics and EHR-driven Clinical Decision Support

Withdrawn NA Last updated 8 November 2021

What this trial tests

NA trial testing Genomind®Professional PGx Express TM in Depression. Withdrawn.

Timeline

1 March 2022

Primary endpoint
28 February 2023

31 December 2023

Quick facts

Lead sponsor	Weill Medical College of Cornell University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Start date	1 March 2022
Primary completion	28 February 2023
Estimated completion	31 December 2023
Sites	1 location across United States

Drugs / interventions tested

Genomind®Professional PGx Express TM

Conditions studied

Depression — all drugs for Depression →

Sponsor

Weill Medical College of Cornell University

Who can join

Adults 18 to 89, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to understand the effectiveness of pharmacogenomic testing in using antidepressants and to understand how EHR - driven clinical decision support system can be used to deliver PGx test results by healhcare providers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality) . · · 2021 · cited 14× · PMID 34484487

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Weill Medical College of Cornell University trials

Trials by the same sponsor.

NCT07485712 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 2 · NA · not yet recruiting
NCT05811338 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1 · NA · not yet recruiting
NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT06818734 — Implementation of a Clinical Decision Support Tool for Postpartum Depression · NA · not yet recruiting
NCT07485725 — Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 3 · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03952494 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Weill Medical College of Cornell University
Last refreshed: 8 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03952494.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing